Physician profile
Walter William Strauser
NPI 1518957521
$2,035.10
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $189 · 2021: $505 · 2022: $722 · 2023: $102 · 2024: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $465.02 | 2019-2023 | Ztlido |
| Biohaven Pharmaceutical Holding Company LTD. | $361.26 | 2022 | |
| Collegium Pharmaceutical, INC. | $210.95 | 2019-2022 | |
| Axogen | $192.78 | 2024 | Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Abbvie INC. | $166.36 | 2022-2023 | Ubrelvy |
| Medtronic, INC. | $164.22 | 2024 | Mazor X System |
| Biohaven Pharmaceuticals, INC. | $146.58 | 2021 | |
| Amgen INC. | $117.30 | 2019 | |
| Pfizer INC. | $62.15 | 2021 | |
| Lilly USA, LLC | $52.68 | 2020-2021 | |
| Bioventus LLC | $18.48 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.22 | 2021 | |
| Indivior INC. | $17.37 | 2022 | |
| Piramal Critical Care | $14.56 | 2019 | |
| Nevro Corp. | $14.33 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Metacel Pharmaceuticals LLC | $12.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Strauser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.